![](/img/cover-not-exists.png)
P998 BENEFIT OF SORAFENIB ACCORDING TO UNDERLYING LIVER DISEASE ETIOLOGY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Bouattour, M., Goutte, N., Vullierme, M.-P., Castelnau, C., Farges, O., Faivre, S., Durand, F., Castera, L.Volume:
60
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(14)61158-2
Date:
April, 2014
File:
PDF, 55 KB
english, 2014